INSILICA, LLC

SANTA CLARA, CA · Software · Still private

Software platform that automates evidence synthesis and regulatory report generation for toxicology assessments

Claim this profile

Follows are private to you and power your alerts

Updated · insilica.co

Sector
Software
Headquarters
SANTA CLARA, CA
Latest Form D
$2.1M, Nov 2009
Total capital
$5.4M
Federal grants
$3.3M
7 awards · 2020–2026
Rank in peer group#12 of 16
Private capital raised
$2.1M
1 Form D · last Nov 2009
203 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $5.4M$251K$256K$294K$296K$1M$1M1st Form D$2.1M
20092013201720212025FEDERAL ↑EQUITY ↓Cumulative $5.4M$296K$1M$1M1st Form D$2.1M

Latest events

  • Federal grantHealth and Human S · Phase II · srvc-EHSR: Sysrev Version Control - Environmental and Health Related Systematic Reviews$1M
  • Federal grantHealth and Human S · Phase II · srvc-EHSR: Sysrev Version Control - Environmental and Health Related Systematic Reviews$1M
  • Federal grantHealth and Human S · Phase I · BioBricks-Env: AI driven, open-source, modular, composable platform to organize, store, retrieve, extract, and integrate environmental health & risk related data$296K
  • Federal grantHealth and Human S · Phase I · srvc-EHSR: Sysrev Version Control - Environmental and Health Related Systematic Reviews$294K
  • Federal grantHealth and Human S · Phase I · ToxIndex-CPG: Machine learning driven platform integrating a hazard susceptibility database to quantify chemical toxicity factors, predict risk levels and classify biological responses$256K
  • Federal grantHealth and Human S · Phase I · Survive-OUD: AI Platform to Integrate Complex Data Sources, Predict Relapse, and Recommend Interventions for Opioid Use Disorder$251K
  • Federal grantNSF · Phase I · SBIR Phase I: Advanced Cancer Analytics Platform for Highly Accurate and Scalable Survival Models to Personalize Oncology Strategies$224K
  • Private capital raisedForm D · SEC · 1st filing$2.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 16 peers

Line = median

Software · Platform

  • Federal grantsBelow median

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Balaji BakthaExecutive OfficerNamed in SEC Form D filings
  • Mustafiz ChoudhuryExecutive OfficerNamed in SEC Form D filings
  • Ravi M. UgaleDirectorNamed in SEC Form D filings
  • Tushar DaveExecutive Officer, DirectorNamed in SEC Form D filings
  • Vinod DahmDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .